A TGF βRII frameshift-mutation-derived CTL epitope recognised by HLA-A2-restricted CD8+ T cells

被引:67
作者
Sæterdal, I
Gjertsen, MK
Straten, P
Eriksen, JA
Gaudernack, G
机构
[1] Univ Oslo, Norwegian Radium Hosp, Dept Immunol, Sect Immunotherapy, N-0310 Oslo, Norway
[2] Danish Canc Soc, Div Canc Biol, Dept Tumor Cell Biol, Copenhagen, Denmark
[3] Hydro Res Ctr, Porsgrunn, Norway
关键词
CTL epitope; microsatellite instability; TGF beta RII frameshift mutation;
D O I
10.1007/s002620100222
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Microsatellite instability (MSI) is recognised as genome-wide alterations in repetitive DNA sequences caused by defects in the DNA mismatch repair machinery. Such mutation patterns have been found in almost all analysed malignancies from patients with hereditary non-polyposis colorectal cancer, and in approximately 15% of sporadic colorectal cancers. In cancers with the MSI phenotype, micro satellite-like sequences in coding regions of various cancer-related genes, including transforming growth factor beta receptor type II (TGF beta RII), are targets for mutations. The TGF beta RII gene harbours a 10-bp polyadenine tract, and mutations within this region are found in 90% of colorectal cancers with MSI. The frameshift mutations result in new amino acid sequences in the C-terminal part of the proteins, prematurely terminating where a novel stop codon appears. In this study we have defined a new cytotoxic T lymphocyte (CTL) epitope (RLSSCVPVA), carrying a good HLA-A*0201 binding motif. and resulting from the most common frameshift mutation in TGF beta RII. A CTL line and several CTL clones were generated from an HLA-A2(+) normal donor by repeated stimulation of T cells with dendritic cells pulsed with the peptide. One of the CTL clones was able to kill an HLA-A2(+) colon cancer cell line harbouring mutant TGF beta RII. This epitope may be a valuable component in cancer vaccines directed at MSI-positive carcinomas.
引用
收藏
页码:469 / 476
页数:8
相关论文
共 26 条
  • [1] Dendritic cells and the control of immunity
    Banchereau, J
    Steinman, RM
    [J]. NATURE, 1998, 392 (6673) : 245 - 252
  • [2] Selection for beta(2)-microglobulin mutation in mismatch repair-defective colorectal carcinomas
    Bicknell, DC
    Kaklamanis, L
    Hampson, R
    Bodmer, WF
    Karran, P
    [J]. CURRENT BIOLOGY, 1996, 6 (12) : 1695 - 1697
  • [3] BETA(2)-MICROGLOBULIN GENE-MUTATIONS - A STUDY OF ESTABLISHED COLORECTAL CELL-LINES AND FRESH TUMORS
    BICKNELL, DC
    ROWAN, A
    BODMER, WF
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (11) : 4751 - 4755
  • [4] TISSUE TYPING THE HLA-A LOCUS FROM GENOMIC DNA BY SEQUENCE-SPECIFIC PCR - COMPARISON OF HLA GENOTYPE AND SURFACE EXPRESSION ON COLORECTAL TUMOR-CELL LINES
    BROWNING, MJ
    KRAUSA, P
    ROWAN, A
    BICKNELL, DC
    BODMER, JG
    BODMER, WF
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (07) : 2842 - 2845
  • [5] High prevalence of activated intraepithelial cytotoxic T lymphocytes and increased neoplastic cell apoptosis in colorectal carcinomas with microsatellite instability
    Dolcetti, R
    Viel, A
    Doglioni, C
    Russo, A
    Guidoboni, M
    Capozzi, E
    Vecchiato, N
    Macrì, E
    Fornasarig, M
    Boiocchi, M
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 1999, 154 (06) : 1805 - 1813
  • [6] DIFFERENTIAL SENSITIVITY OF SUBCLASSES OF HUMAN-COLON CARCINOMA CELL-LINES TO THE GROWTH INHIBITORY EFFECTS OF TRANSFORMING GROWTH FACTOR-BETA-1
    HOOSEIN, NM
    MCKNIGHT, MK
    LEVINE, AE
    MULDER, KM
    CHILDRESS, KE
    BRATTAIN, DE
    BRATTAIN, MG
    [J]. EXPERIMENTAL CELL RESEARCH, 1989, 181 (02) : 442 - 453
  • [7] APC mutations in colorectal tumors with mismatch repair deficiency
    Huang, J
    Papadopoulos, N
    McKinley, AJ
    Farrington, SM
    Curtis, LJ
    Wyllie, AH
    Zheng, S
    Willson, JKV
    Markowitz, SD
    Morin, P
    Kinzler, KW
    Vogelstein, B
    Dunlop, MG
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (17) : 9049 - 9054
  • [8] Transforming growth factor β stimulation of colorectal cancer cell lines:: Type II receptor bypass and changes in adhesion molecule expression
    Ilyas, M
    Efstathiou, JA
    Straub, J
    Kim, HC
    Bodmer, WF
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (06) : 3087 - 3091
  • [9] IMANISHI T, 1992, P 11 INT HIST WORKSH, V1, P1065
  • [10] CTL-defined cancer vaccines:: Perspectives for active immunotherapeutic interventions in minimal residual disease
    Jäger, E
    Jäger, D
    Knuth, A
    [J]. CANCER AND METASTASIS REVIEWS, 1999, 18 (01) : 143 - 150